Navigation Links
Neuro Kinetics: Research Suggests I-Portal(R) NOTC Data Shows Mild Traumatic Brain Injuries That Other Technologies Miss
Date:3/4/2009

Unique Case Study of Patient Before & After mTBI Accident

Presentation at American Balance Society, Case Study on Web Site, New Help for Returning Vets

PITTSBURGH, March 4 /PRNewswire/ -- With record numbers of American soldiers returning from Iraq and Afghanistan with brain injuries, a case study from Neuro Kinetics, Inc. (NKI) (www.neuro-kinetics.com) suggests that tests utilizing its I-Portal(R) NOTC (Neuro-Otologic Test Center) system can generate results that may indicate mild traumatic brain injuries (mTBI) that are not detected by other evaluation technologies.

NKI manufactures noninvasive medical test equipment used worldwide in the evaluation of balance, vestibular and neurological disorders.

The details of the new case study are available on NKI's Web site (http://www.neuro-kinetics.com/docs/Mild-Traumatic-Brain-Injury.pdf). The findings are being presented today at an American Balance Society conference in Scottsdale, AZ.

The paper's authors are Brian J. McKinnon, MD, MBA, assistant professor, Otology/Neurotology, Department of Otolaryngology-Head & Neck Surgery, Medical College of Georgia; Alex Kiderman, PhD, NKI's chief technology officer; and Terri E. Ives, ScD, AuD, F-AAA, CCC-A, NKI's clinical director - audiology.

The case study features unique pre- and post-accident neuro-otologic test data gathered from one individual, a NKI employee who had undergone various I-Portal NOTC evaluations as part of routine product testing and then again after he suffered a bicycle accident last year.

"The situation with our colleague presented us with a rare opportunity to evaluate a patient after an accident and then to compare those results to baseline data previously collected," explained Kiderman.

"Clinicians who deal with brain injuries will be intrigued by our findings. The I-Portal NOTC system collected data that appears to be able to indicate mild traumatic brain injuries that other evaluation methods missed," Kiderman said. "The patient in our study had undergone a CT scan after his accident, but those results were negative. The I-Portal NOTC's were not. The patient felt he was not healthy, and our results support that.

"We believe this case study may shed new light on how medical professionals can identify mild traumatic brain injuries and traumatic brain injuries," Kiderman added. "We are continuing our work in this vital area and hope that others will be encouraged by our results and will pursue additional research."

Specific tests conducted on the NKI employee before and after his accident and reported in the case study included optokinetic (OKN), spontaneous, pendular tracking, saccade, horizontal and vertical gaze, subjective visual vertical (SVV) and subjective visual horizontal (SVH), head thrust test (HTT), and sinusoidal harmonic acceleration test (SHA). The HTT test is currently investigational.

ABOUT NEURO KINETICS, INC.

Neuro Kinetics, Inc. (www.neuro-kinetics.com) is a fast-growing manufacturer of noninvasive medical test equipment used worldwide by audiologists, neurologists, neuro-otologists, ophthalmologists, otolaryngologists and other medical specialists in the detection and evaluation of neurological, otological and vestibular disorders. The privately owned company, founded in the 1970s, pioneered the development of vestibular and neuro-otologic testing equipment, including the renowned Barany (rotational) chair. The company's products include the I-Portal(R) NOTC System (Neuro-Otologic Test Center), I-Portal(R) VNG (Video Nystagmography) system and I-Portal(R) VOG (Video-Oculography) system, along with related accessories, software, training and support services. Users include doctors and researchers in universities and government facilities as well as specialists in fields such as audiology, neurology, neuro-otology, ophthalmology and otolaryngology.

    MEDIA CONTACT:
    John Buckman
    Buckman Communications
    412 381 2900
    jbuckman@buckman.biz


'/>"/>
SOURCE Neuro Kinetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)
2. Results of NeuroThera Effectiveness and Safety Trial - 2 (NEST-2) Presented at International Stroke Conference 2009
3. Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test
4. Genetic Research Leads to New Discovery in Understanding Rare Neurological Disorder
5. Study Shows How Defective DNA Repair Triggers Two Neurological Diseases
6. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
7. Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis
8. Neuronetrix Announces Preliminary Alzheimers Study Results at the Society for Neuroscience Conference
9. Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting
10. Neuronascent, Inc. Receives Multiple Fundings for Its Neurogenesis Therapeutic Programs
11. Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , March 28, 2017 Elysium ... with Cambridge academic ...   The Milner Therapeutics Institute today announces Elysium ... Health has committed significant investment for collaborative projects with academic ... four years. This is the first major research investment outside ...
(Date:3/27/2017)... Summary This report provides ... its partnering interests and activities since 2010. Description The ... insight into the partnering activity of one of the world,s ... are prepared upon purchase to ensure inclusion of the most ... report will be delivered in PDF format within 1 working ...
(Date:3/27/2017)... Therapix Biosciences Ltd. (NASDAQ: ... the development of cannabinoid-based drugs, today announced the ... the United States of 2,000,000 American ... shares of the Company, at a price of ... the underwriters a 45-day over-allotment option to purchase ...
Breaking Medicine Technology:
(Date:3/28/2017)... Angeles, CA (PRWEB) , ... March 28, 2017 ... ... credential, which will be offered by the American Association of Integrative Medicine and ... presentations for healthcare providers at the AutismOne 2017 Conference in Colorado Springs. , ...
(Date:3/28/2017)... Square, PA (PRWEB) , ... March 28, 2017 , ... ... online and across a variety of business channels. , While many results are ... of any public relations program. , When it comes to measurement, firms should ...
(Date:3/28/2017)... , ... March 28, 2017 , ... With expansion and ... Georgia, in early March. , The seed processing plant opened in Marshallville in 2006, ... 2016. The new office allows opportunity for transition of Patten Seed operations to the ...
(Date:3/28/2017)... ... 2017 , ... Oily skin is a common and unwelcomed occurrence in people of all ages, ... to offer to the discussion of dealing with excess skin oil. “Oily skin is a ... remedies that can help remove the oily shine while keeping the skin fresh and clean,” ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... in their profession as their value increases in the healthcare workforce, according to ... such as job boards, career fairs, and candidate leads to healthcare employers of ...
Breaking Medicine News(10 mins):